Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Akari Therapeutics Plc | 618,658 | reported | 16 Dec 2025 | tx 25+5,574,574,060 |
| CytoDyn Inc. | 0 | reported | 24 Nov 2021 | tx 15+1,143,237−924,658 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 16 Dec 2025 | PURCHASE | Akari Therapeutics Plc | 231,997 | — | deriv |
| 16 Dec 2025 | PURCHASE | Akari Therapeutics Plc | 618,658 | 0.40 USD | deriv |
| 16 Dec 2025 | PURCHASE | Akari Therapeutics Plc | 618,658 | — | deriv |
| 16 Dec 2025 | PURCHASE | Akari Therapeutics Plc | 231,997 | 0.40 USD | deriv |
| 20 Mar 2025 | GRANT_AWARD | Akari Therapeutics Plc | 225,000 | 0.00 USD | deriv |
| 20 Mar 2025 | GRANT_AWARD | Akari Therapeutics Plc | 175,000 | 0.00 USD | deriv |
| 06 Mar 2025 | GRANT_AWARD | Akari Therapeutics Plc | 406,250 | 1.12 USD | |
| 06 Mar 2025 | GRANT_AWARD | Akari Therapeutics Plc | 406,250 | 1.12 USD | deriv |
| 06 Mar 2025 | GRANT_AWARD | Akari Therapeutics Plc | 406,250 | 1.12 USD | deriv |
| 03 Jan 2025 | GRANT_AWARD | Akari Therapeutics Plc | 208,000 | 0.00 USD | |
| 03 Jan 2025 | GRANT_AWARD | Akari Therapeutics Plc | 152,672,000 | 0.00 USD | deriv |
| 26 Dec 2024 | GRANT_AWARD | Akari Therapeutics Plc | 3,200,000 | 0.00 USD | |
| 27 Dec 2024 | GRANT_AWARD | Akari Therapeutics Plc | 400,000 | 0.00 USD | |
| 24 Dec 2024 | GRANT_AWARD | Akari Therapeutics Plc | 7,500,000 | 0.00 USD | |
| 23 Dec 2024 | GRANT_AWARD | Akari Therapeutics Plc | 1,400,000 | 0.00 USD | |
| 20 Dec 2024 | GRANT_AWARD | Akari Therapeutics Plc | 1,400,000 | 0.00 USD | |
| 02 Dec 2024 | GRANT_AWARD | Akari Therapeutics Plc | 419,286,000 | 0.00 USD | |
| 30 Nov 2024 | GRANT_AWARD | Akari Therapeutics Plc | 162,604,000 | 0.00 USD | deriv |
| 02 Dec 2024 | GRANT_AWARD | Akari Therapeutics Plc | 419,286,000 | 0.00 USD | deriv |
| 14 Nov 2024 | GRANT_AWARD | Akari Therapeutics Plc | 1,404,622,000 | — | |
| 31 Oct 2024 | GRANT_AWARD | Akari Therapeutics Plc | 79,684,000 | 0.00 USD | deriv |
| 30 Sept 2024 | GRANT_AWARD | Akari Therapeutics Plc | 175,080,000 | 0.00 USD | deriv |
| 30 Jun 2024 | GRANT_AWARD | Akari Therapeutics Plc | 91,396,000 | 0.00 USD | |
| 31 May 2024 | GRANT_AWARD | Akari Therapeutics Plc | 1,326,258,000 | 0.00 USD | |
| 31 May 2024 | GRANT_AWARD | Akari Therapeutics Plc | 1,326,258,000 | 0.00 USD | deriv |